Samuel Lanre

Samuel Lanre (ACA) currently serves as the Finance Planning & Analysis Manager at Swiss Pharma Nigeria, where he plays a pivotal role in steering the company's financial strategy and operational efficiency. With a robust background as a Chartered Accountant and a Master’s in Business Administration, Samuel brings a comprehensive understanding of financial management, budgeting, and strategic planning to his role. His expertise encompasses a wide array of financial systems, including HFM (Atlas), SAP ECC and S/4HANA, Microsoft Dynamics Navision, JD Edwards, and IBM Cognos (Polaris), enabling him to deliver precise financial reporting and insightful analysis.

In his capacity, Samuel oversees the budget planning process, ensuring alignment with corporate objectives and facilitating effective resource allocation. He is instrumental in coordinating and preparing budgets, conducting detailed reviews and variance analyses of monthly management reports, and providing analytical support to the sales team for target setting and performance evaluation. His proficiency in financial analysis and forecasting allows him to identify cost-saving opportunities and optimize departmental performance, contributing significantly to Swiss Pharma’s financial health and operational excellence.

Samuel’s role also involves preparing comprehensive financial reports for group stakeholders using advanced tools like Hyperion Financial Management and Polaris, ensuring compliance with international standards such as IFRS. His skills in P&L review, treasury management, and bank reconciliation further enhance his ability to deliver timely, accurate financial insights. Known for his integrity, versatility, and commitment to excellence, Samuel Lanre continues to be a vital asset in driving Swiss Pharma Nigeria’s financial strategy and sustainable growth within the competitive pharmaceutical industry.